Search for: "SCA Pharmaceuticals Inc." Results 1 - 20 of 31
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Nov 2021, 2:07 pm by Kevin LaCroix
  SCA loss mitigation will limit unfavorable development overhangs of more current SCA vintages on future and potential ESG-related claims. [read post]
9 Mar 2022, 2:06 pm by Kevin LaCroix
  The largest 2021 settlements included one settlement in excess of $1 billion (the $1.21 billion settlement in the Valeant Pharmaceuticals International case) and four in excess of $100 million (Snap, Inc.: $187.5 million; DaVita, Inc.: $135 million; Allergan plc: $130 million; and GCI Liberty $110 million). [read post]
14 Dec 2023, 10:00 pm by Chijioke Okorie
According to the SCA, the High Court should have considered the marks as wholes, rather than the exact details of each and/or comparing only the pictures in the marks. [read post]
5 Sep 2016, 6:46 pm by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
25 Jan 2022, 3:11 pm by Kevin LaCroix
  Two of the 2021 settlements were large enough to qualify for ISS SCAS’s list of the Top 100 securities class action lawsuit settlements of all time: Valeant Pharmaceuticals, Inc., $1.21 billion, which is the 9th largest of all time; and Snap, Inc. $187.5 million (inclusive of both federal and state settlements), which is the 97th largest settlement. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
4 Mar 2021, 2:03 pm by Kevin LaCroix
  There have already been several significant settlements that appear positioned for court approval in 2021, including the $1.21 billion settlement regarding Valeant Pharmaceuticals and Snap, Inc. [read post]
28 Jun 2016, 6:41 am by Dennis Crouch
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
17 Feb 2016, 9:20 am by Dennis Crouch
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
17 Mar 2020, 1:32 pm by Noble McIntyre
Eco-Gel 200 ultrasound gel has been recalled by Eco-Med Pharmaceutical, Inc. due to bacterial contamination. [read post]
18 Apr 2016, 9:58 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
28 Feb 2023, 12:22 pm by Kevin LaCroix
The top five 2022 North American settlements included Twitter ($809.5 million); Teva Pharmaceutical Industries, Ltd. ($420 million); Luckin Coffee, Inc. ($175 million); BlackBerry Ltd. ($165 million); and NovaStar Mortgage ($165 million). [read post]